Sai Life Sciences IPO

NiftyTrader • December 6, 2024

Post Views: 93

Sai Life Sciences IPO opens for subscription on December 11, 2024 and closes on December 13, 2024. The allotment for the Sai Life Sciences IPO is expected to be finalized on Monday, December 16, 2024. Sai Life Sciences IPO will list on BSE, NSE with tentative listing date fixed as Wednesday, December 18, 2024.

Sai Life Sciences IPO price band is set at ₹522 to ₹549 per share. The minimum lot size for an application is 27 Shares. The minimum amount of investment required by retail investors is ₹14,823. The minimum lot size investment for sNII is 14 lots (378 shares), amounting to ₹207,522, and for bNII, it is 68 lots (1,836 shares), amounting to ₹1,007,964.

Sai Life Sciences IPO is a book built issue of Rs 3,042.62 crores. The issue is a combination of fresh issue of 1.73 crore shares aggregating to Rs 950.00 crores and offer for sale of 3.81 crore shares aggregating to Rs 2,092.62 crores.

Sai Life Sciences IPO Details

IPO Date	December 11, 2024 to December 13, 2024
Listing Date	[.]
Face Value	₹1 per share
Price	₹522 to ₹549 per share
Lot Size	27 Shares
Total Issue Size	55,421,123 shares (aggregating up to ₹3,042.62 Cr)
Fresh Issue	17,304,189 shares (aggregating up to ₹950.00 Cr)
Offer for Sale	38,116,934 shares of ₹1 (aggregating up to ₹2,092.62 Cr)
Issue Type	Book Built Issue IPO
Listing At	BSE, NSE
Shareholding pre-issue	190,685,340
Share holding post issue	207,989,529

Sai Life Sciences IPO Lot Size

Investors can bid for a minimum of 27 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.

Application	Lots	Shares	Amount
Retail (Min)	1	27	₹14,823
Retail (Max)	13	351	₹192,699
S-HNI (Min)	14	378	₹207,522
S-HNI (Max)	67	1,809	₹993,141
B-HNI (Min)	68	1,836	₹1,007,964

Sai Life Sciences IPO Objectives

The company propose to utilise the Net Proceeds towards funding the following objects:

Repayment/prepayment in full or part, of all or certain outstanding borrowings availed by the Company and
General corporate purposes

About Sai Life Sciences

Incorporated in January 1999, Sai Life Sciences Limited researches, develops, and manufactures small-molecule new chemical entities. The company offers tailor-made services to biotech firms and global pharma companies.

In the Financial Year 2024 and for the month ending September 30, 2024, the company provided services to over 280 innovator pharmaceutical companies, including more than 230 in that month alone. Among these clients, the company worked with 18 of the top 25 pharmaceutical companies based on their revenue in the calendar year 2023.The services were offered across countries such as the US, the UK, Europe, and Japan.

The company’s business development team consists of 16 experienced and qualified professionals, with six located in the US, nine in the UK and Europe, and one in Japan.

The company has the following service offerings.

Capabilities in chemistry, manufacturing, and control(“CMC”)/contract development and manufacturing organisations (“CDMO”).
CRO services include integrated discovery (“Discovery”) capabilities across biology, chemistry, drug metabolism and pharmacokinetics

As of September 30, 2024, the company had 2,353 scientific staff, with the majority of the scientific team holding advanced degrees, including 302 Ph. D.s and 1,475 master’s degrees.

As of September 30, 2024, the company had 3135 employees with capabilities across the CRDMO value chain.

Competitive Strength:

CDMO platform with a diverse mix of commercial and under-development molecules

As an integrated CRDMO, the company provide a complete platform for discovery, development, and manufacturing.

CRO services include integrated discovery capabilities across biology, chemistry, and drug metabolism and pharmacokinetics.

Sai Life Sciences Financial Information

Period Ended	30 Sep 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	2,476.78	2,275.14	2,186.65	2,164.23
Revenue	693.35	1,494.27	1,245.11	897.74
Profit After Tax	28.01	82.81	9.99	6.23
Net Worth	1,044.75	974.34	887.29	877.76
Reserves and Surplus	855.69	953.99	867.43	859.17
Total Borrowing	764.49	710.16	699.23	751.32
				Amount in ₹ Crore

Sai Life Sciences IPO Reservation

Investor Category	Shares Offered
QIB Shares Offered	Not more than 50% of the Net Issue
Retail Shares Offered	Not less than 35% of the Net Issue
NII (HNI) Shares Offered	Not less than 15.00% of the Net Issue

Sai Life Sciences IPO Timeline (Tentative Schedule)

Sai Life Sciences IPO opens on December 11, 2024, and closes on December 13, 2024.

IPO Open Date	Wednesday, December 11, 2024
IPO Close Date	Friday, December 13, 2024
Basis of Allotment	Monday, December 16, 2024
Initiation of Refunds	Tuesday, December 17, 2024
A credit of Shares to Demat	Tuesday, December 17, 2024
Listing Date	Wednesday, December 18, 2024
Cut-off time for UPI mandate confirmation	5 PM on December 13, 2024